Home page  |  Help  |  Clear
English  |  French
 Search  |  Categories  |  Titles A-Z  |  Countries  |  Compare countries  |  Index  
Full TOC
Expand Document
Expand Chapter
Preferences

close this bookKenya Essential Drugs List (WHO; 2003; 25 pages)
View the documentAcknowledgement
View the documentForeword
View the documentIntroduction to the 2002 Kenya Essential Drugs List
View the documentCriteria for Selection of Essential Drugs
View the documentGuidelines for Selection of the Secondary Schedule Drugs
View the documentEssential Drugs List Revision Request Form
View the documentExplanatory Notes
Open this folder and view contentsEssential Drugs List
 

Essential Drugs List Revision Request Form

The Kenya Essential Drugs List is meant to be a ‘living list’. Regular revisions are planned. The Ministry of Health recognizes that the revision process will benefit greatly from the experience and recommendations of clinicians, pharmacists, and scientists involved in prescribing, dispensing, and studying pharmaceutical products in Kenya. Any individual who wishes to suggest additions, deletions, or other changes to the Kenya Essential Drugs List should complete the following form and submit it to the Chief Pharmacist, Ministry of Health, Afya House, Cathedral Road, P.O. Box 30016, Nairobi.

For additions, the form asks the person requesting the change to provide therapeutic information on the proposed drug. Also, there should be a brief explanation of the advantages of the drug over drugs currently on the list. The form also requests comparative cost information, to be provided by the Kenya Medical Supplies Agency (KEMSA).

All completed Kenya Essential Drugs List Revision Request Forms will be considered during the next revision of the Kenya Essential Drugs List.

Government of Kenya, Ministry of Health
ESSENTIAL DRUGS LIST REVISION REQUEST FORM

TYPE OF REQUEST:

ADDITION

DELETION

CHANGE

SECTION A.

To be completed by individual initiating request

Generic Name: ______________________________________________________

Dosage Form & Strength: ______________________________________________

Best Known Brand Names & Manufacturers:

(1) _________________________________________________________________

(2) _________________________________________________________________

For ADDITIONS, what similar-acting drugs are now on Essential Drugs List?

(1) _____________________________(2)__________________________________

State reasons for addition, deletion or change. For ADDITIONS, please explain advantage of proposed drugs over similar-acting drugs listed above. Continue on reverse side, if necessary.
___________________________________________________________________
___________________________________________________________________

SECTION B.

To be completed by KEMSA for proposed ADDITIONS

Estimated cost of proposed drug: Kshs. ______________ Per _________________

Current cost of similar acting drugs on Essential Drugs List:

(1) Name & Strength ______________ Kshs. ____________ Per ______________

(2) Name & Strength ______________ Kshs. ____________ Per_______________

SECTION C.

To be completed by Essential Drugs List Committee

ACTION TAKEN ON THE REQUEST:

Approved

Rejected

FOR NEW DRUGS:

Dosage form & strength approved: _____________________________________

Level of Use:

_KNH

_PGH

_DH

_SDH

_Disp

_CWH

_MTRH

___________________
Committee Chairman

_____________
Date

to previous sectionto next section

Please provide your feedback
Abbreviations
English  |  French